Actavis is a leading pharmaceutical group ranked first 50 in worldwide pharmaceutical industry, and 4th in global generic field with the headquarter located in Zug, Swissland. Actavis develops its business in over 40 countries or regions, selling more than 1000 kinds of products. Actavis also has over 600 kinds of products being developed or registered at present. All the products cover in central nervous system, alimentary tract, cardiovascular system, metabolism, anti-infectives, respiratory system, etc.
Actavis (Foshan) is the production, sales & marketing and R&D base in China for Actavis Group. The earliest predecessor of Actavis (Foshan) is the Foshan pharmaceutical plant, which was founded in 1956, and acquired by FH Faulding from Australia in 1994, then by Alpharma from USA in 2001. Actavis (Foshan) became part of Actavis group in late 2005 with the formal name of Actavis (Foshan) Pharmaceutical Co., Ltd.
阿特维斯集团公司是一间总部位于瑞士的制药公司，位居全球医药企业50强，全球通用名药企业4强，其业务遍及全球40个国家。目前在产和销售的产品1000多种，在研发和注册的产品600多种，涉及中枢神经、消化、心血管、代谢、抗感染、呼吸等多个领域。
阿特维斯（佛山）制药有限公司是阿特维斯集团在中国的研发、生产和销售基地，其前身是成立于1956年的佛山制药厂，后来历经澳洲康宝顺（佛山）制药有限公司、美国雅来（佛山）制药有限公司，在2005年底发展成为现在的阿特维斯（佛山）制药有限公司。
中国大陆总部、工厂及研发中心位于广东省佛山市禅城区，在广州设有营销中心，在北京设有政府联络处。
阿特维斯坚持在研发，生产与服务都执行最高标准。我们欢迎与全国经销商一起为顾客提供贴近大众的好药。中国区业务作为阿特维斯全集团发展战略重要的一环，其光明的前景势必为全集团成为更优秀的通用名药企业做出巨大贡献。
Actavis阿特维斯在瑞士楚格的总部大楼气势恢宏